Speaker
Director of S&E, Novartis AG
Xiaodong Zhang, Director of S&E at Novartis AG, appears in the programmes of 2 conferences on kongre.net. Most recently: 11th CAR-TCR Summit 2026 (Boston, United States of America, 15–17 Sept 2026).
15–17 Sept 2026Boston, United States of America
9–10 Sept 2026Boston, United States of America
Chief Technical Officer, Tr1x therapeutics
Executive Director, Analytical Strategy, Cell Therapy Global Quality, Bristol Myers Squibb
Vice President, Immunology, Sail Biomedicines
Chief Technology Officer, Anocca AB
Chief Business Development Officer, PolTREG
Clinical Manufacturing Head, Cartherics Pty Ltd
Science Partner, Flagship Pioneering
Search & Evaluation Lead, GI & Inflammation, Strategy & Portfolio Development, Takeda Pharmaceutical
Chief Business Officer, Nurix Therapeutics, Inc.
Co-Founder & Chief Technology Officer, Sibylla Biotech srl
Chief Executive Officer, Synthis Therapeutics
Chief Executive Officer, Trimtech Therapeutics
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Xiaodong Zhang, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].